Cardiac AI Diagnostics Market Booms to $2.22B Amid Cancer Treatment Need

The global medical imaging market reached $45.5 billion in 2026, with a shift towards AI-native precision for cancer therapies requiring intense heart monitoring. The cardiac AI diagnostic sector is valued at $2.22 billion, driven by the need for continuous imaging to detect heart dysfunction caused by cancer treatments. Companies like VentriPoint Diagnostics, Butterfly Network, RadNet, Nanox Imaging, and OneMedNet are poised to benefit from this convergence, leveraging cloud-based platforms and software-defined 3D modeling to provide MRI-quality results without the high cost.